- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00128765
Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease in General Practice
Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease (COPD) in General Practice. A Randomized Controlled Trial Comparing Regular Practice Nurse Review, Self-management Education and Usual Care
In this randomized controlled trial, three contemporary modes for chronic obstructive pulmonary disease (COPD) management in Dutch general practices are compared for costs and effects:
- usual general practitioner (GP) care (at patient's initiative);
- regular practice nurse review; and
- integrated self-management education.
All three interventions are based on existing guidelines, materials, and field experiences.
Study Overview
Status
Conditions
Detailed Description
Considering the ageing of the Dutch population and the current and increasing shortage of general practitioners (GPs), the capacity of primary healthcare is a major and growing concern. Delegation of care normally provided by GPs with care provided by trained practice nurses is now rapidly emerging for patients with chronic respiratory disease, i.e. asthma and chronic obstructive pulmonary disease (COPD). However, most general practices still provide care at initiative of the patient self, because of the lack in scientific evidence and the costs of implementing a regular care structure. Self-care by patients may be an alternative to alleviate the growing load on primary health care.
The following two main research questions are addressed in this study.
- Does an integrated self-management education intervention for patients with COPD in general practice contribute to attaining long-term treatment targets, compared to regular monitoring by a practice nurse and usual GP care?
- What is the cost-effectiveness of an integrated self-management education intervention for patients with COPD, compared to regular monitoring by a practice nurse and usual GP care?
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nijmegen, Netherlands, 6500 HB
- Radboud University, Department of General Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Registered in one of the general practices participating in the study
- Diagnosis of COPD, with Global Initiative for Chronic Obstructive Lung Diseases (GOLD) stage I, II or III
- Age ≥35 years
- Willing to provide written informed consent
Exclusion Criteria:
- Very poor prognosis with regard to respiratory condition (GOLD stage IV)
- Severe co-morbid conditions with a reduced life expectancy
- Unable to communicate in the Dutch language
- Objections to one or more of the disease management modes in the study
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: usual care
usual care, i.e.
COPD care at patient's own initiative, mostly for medical help during exacerbations
|
care at initiative of the patient (usual GP care)
|
Experimental: monitoring controls
regular COPD care (monitoring) provided by practice nurse according to current COPD guidelines
|
protocol based on existing Guidelines: Dutch College of General Practitioners (NHG) Global Initiative for Chronic Obstructive Lung Disease (GOLD)
|
Experimental: self-management
disease specific self-management program 'Living Well with COPD'
|
disease specific self-management program 'Living Well with COPD', developed in Montreal, Canada
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
disease-specific health-related quality of life (HRQoL)
Time Frame: two years
|
two years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the number of exacerbations
Time Frame: two years
|
two years
|
generic quality of life
Time Frame: two years
|
two years
|
decline post- and pre-bronchodilator (BD) lung function indices
Time Frame: two years
|
two years
|
level of respiratory symptoms
Time Frame: two years
|
two years
|
satisfaction with the health care received
Time Frame: two years
|
two years
|
compliance with (non-) pharmaceutical treatment
Time Frame: two years
|
two years
|
direct and indirect medical costs
Time Frame: two years
|
two years
|
COPD related self-efficacy
Time Frame: two years
|
two years
|
COPD coping styles
Time Frame: two years
|
two years
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Chris van Weel, FRCP, Department of General Practice, Radboud University, Nijmegen, The Netherlands
- Study Director: Tjard Schermer, PhD, Department of General Practice, Radboud University, Nijmegen, The Netherlands
- Principal Investigator: Erik Bischoff, MD, Department of General Practice, Radboud University, Nijmegen, The Netherlands
Publications and helpful links
General Publications
- Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, Renzi P, Nault D, Borycki E, Schwartzman K, Singh R, Collet JP; Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Sante du Quebec. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med. 2003 Mar 10;163(5):585-91. doi: 10.1001/archinte.163.5.585.
- Monninkhof E, van der Valk P, van der Palen J, van Herwaarden C, Partridge MR, Zielhuis G. Self-management education for patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 2003 May;58(5):394-8. doi: 10.1136/thorax.58.5.394.
- Bourbeau J, Nault D, Dang-Tan T. Self-management and behaviour modification in COPD. Patient Educ Couns. 2004 Mar;52(3):271-7. doi: 10.1016/S0738-3991(03)00102-2.
- Bischoff EW, Akkermans R, Bourbeau J, van Weel C, Vercoulen JH, Schermer TR. Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial. BMJ. 2012 Nov 28;345:e7642. doi: 10.1136/bmj.e7642.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MONC95582
- ZonMw grant: 945.04.230 (Other Grant/Funding Number: ZonMw)
- Picasso grant: 005.2004 (Other Grant/Funding Number: Picasso)
- CMO: 2004/249 (Other Identifier: Medical Ethics Committee)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Diseases, Obstructive
-
Assistance Publique - Hôpitaux de ParisCompletedChronic Obstructive Lung Disease (COLD)France
-
Centre Hospitalier Intercommunal CreteilRecruitingChronic Obstructive Pulmonary Disease | Chronic Obstructive Lung DiseaseFrance
-
Heidelberg UniversityTerminatedObstructive Lung DiseasesAustralia, Germany
-
PharmaLundensis ABCompletedChronic Obstructive Lung DiseaseSweden
-
Imperial College LondonAstraZenecaCompleted
-
Columbia UniversityAstraZenecaTerminated
-
Philip DiazCompletedChronic Obstructive Lung DiseaseUnited States
-
University Hospital, Gentofte, CopenhagenCompletedChronic Obstructive Lung DiseaseDenmark
-
Schön Klinik Berchtesgadener LandCompletedChronic Obstructive Lung Disease
-
Rigshospitalet, DenmarkLundbeck FoundationCompleted
Clinical Trials on care at initiative of the patient (usual GP care)
-
Georgetown UniversityNational Cancer Institute (NCI)Completed
-
The Hospital for Sick ChildrenHamilton Health Sciences Corporation; London Health Sciences Centre; Children...Completed
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedMemory Disorders | Delirium, Dementia, Amnestic, Cognitive DisordersNetherlands
-
Kuopio University HospitalUniversity of Eastern Finland; Siilinjärvi Health CenterActive, not recruitingHypertension | Diabetes Mellitus | Ischemic Heart DiseaseFinland
-
Hospices Civils de LyonCompletedSevere Heart FailureFrance
-
Vrije Universiteit BrusselHogeschool AntwerpenTerminated
-
Massachusetts General HospitalMedically HomeActive, not recruitingLymphoma | Head and Neck Cancer | Pancreatic Cancer | Rectal Cancer | GastroEsophageal CancerUnited States
-
University of CalgaryAlberta Health services; University of AlbertaCompletedStroke | Epilepsy | Autoimmune Diseases | Endocrine System Diseases | Diabetes | Hematologic Diseases | Genetic Diseases, Inborn | Traumatic Brain Injury | Autism Spectrum Disorder | Respiratory Disease | Cardiac Disease | Metabolic Disease | Renal Disease | Neuro-Degenerative Disease | Fetal Alcohol Spectrum Disorders | Gastro-Intestinal DisorderCanada
-
Alison GalbraithHarvard School of Public Health (HSPH); Agency for Healthcare Research and... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease | Hospital Readmission | Congestive Heart Failure | Post-discharge Care TransitionsUnited States
-
San Diego State UniversityNational Institute of Mental Health (NIMH)Completed